These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke. Ueda S; Weir CJ; Inglis GC; Murray GD; Muir KW; Lees KR J Hypertens; 1995 Dec; 13(12 Pt 2):1597-601. PubMed ID: 8903617 [TBL] [Abstract][Full Text] [Related]
26. Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. Johnston CI J Hypertens Suppl; 1992 Dec; 10(7):S13-26. PubMed ID: 1337911 [TBL] [Abstract][Full Text] [Related]
27. ACE-DD genotype is associated with the occurrence of acute coronary syndrome in postmenopausal women. Méthot J; Hamelin BA; Bogaty P; Arsenault M; Plante S; Poirier P Int J Cardiol; 2005 Dec; 105(3):308-14. PubMed ID: 16274774 [TBL] [Abstract][Full Text] [Related]
28. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene. Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861 [TBL] [Abstract][Full Text] [Related]
29. Multilocus analysis in candidate genes ACE, AGT, and AGTR1 and predisposition to peripheral arterial disease: role of ACE D/-240T haplotype. Fatini C; Sticchi E; Sofi F; Said AA; Pratesi G; Pulli R; Pratesi C; Abbate R J Vasc Surg; 2009 Dec; 50(6):1399-404. PubMed ID: 19782519 [TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286 [TBL] [Abstract][Full Text] [Related]
31. Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. Beohar N; Damaraju S; Prather A; Yu QT; Raizner A; Kleiman NS; Roberts R; Marian AJ J Investig Med; 1995 Jun; 43(3):275-80. PubMed ID: 7614074 [TBL] [Abstract][Full Text] [Related]
35. The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases. Lazartigues E; Feng Y; Lavoie JL Curr Pharm Des; 2007; 13(12):1231-45. PubMed ID: 17504232 [TBL] [Abstract][Full Text] [Related]
36. Role of the renin-angiotensin system as a risk factor for control of morbidity and mortality in coronary artery disease. Riegger GA Cardiovasc Drugs Ther; 1996 Nov; 10 Suppl 2():613-5. PubMed ID: 9115954 [TBL] [Abstract][Full Text] [Related]
37. [The role of angiotensin-converting enzyme gene I/D polymorphism in development of metabolic disorders in patients with cardiovascular pathology]. Vynohradova SV Tsitol Genet; 2005; 39(1):63-70. PubMed ID: 16018179 [TBL] [Abstract][Full Text] [Related]
38. Acute stress and cardiovascular health: is there an ACE gene connection? Holman EA J Trauma Stress; 2012 Oct; 25(5):592-7. PubMed ID: 23055331 [TBL] [Abstract][Full Text] [Related]
39. Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease. Schunkert H J Mol Med (Berl); 1997; 75(11-12):867-75. PubMed ID: 9428619 [TBL] [Abstract][Full Text] [Related]
40. Angiotensin-converting enzyme I/D and alpha-adducin Gly460Trp polymorphisms: from angiotensin-converting enzyme activity to cardiovascular outcome. Li Y; Zagato L; Kuznetsova T; Tripodi G; Zerbini G; Richart T; Thijs L; Manunta P; Wang JG; Bianchi G; Staessen JA Hypertension; 2007 Jun; 49(6):1291-7. PubMed ID: 17452507 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]